How is sample size calculated for comparing two proportions?

The Fleiss formula utilizes standard normal critical values for significance level (alpha) and statistical power (1-beta), combined with the pooled proportion and expected difference.

What is the standard statistical power for clinical studies?

Most clinical and epidemiological studies require a statistical power of 80% (0.80) or 90% (0.90), corresponding to a 20% or 10% risk of Type II error (beta).

Sample Size Calculator for Clinical Trials & Research

Determine the required sample size for two independent study cohorts (proportions or continuous means) to guarantee target statistical power (1 − β) at your chosen significance level (α).

Sample Size Principles in Clinical Research

In clinical trials and comparative observational studies, determining the sample size prior to patient recruitment is both an ethical obligation and a regulatory requirement. An underpowered study risks failing to detect a true therapeutic difference (committing a Type II error), while an overpowered study exposes excessive human subjects to experimental risks and consumes unnecessary financial resources.

Mathematical Formulations

For comparing two independent binary proportions ($p_1$ and $p_2$) with equal allocation ($1:1$), LabStats implements the standard Fleiss formulation with unpooled variance:

$$n = \frac{\left(Z_{1-\alpha/2} \sqrt{2\bar{p}(1-\bar{p})} + Z_{1-\beta} \sqrt{p_1(1-p_1) + p_2(1-p_2)}\right)^2}{(p_1 - p_2)^2}$$

Where:

$\bar{p} = \frac{p_1 + p_2}{2}$ is the average pooled proportion across both groups.
$Z_{1-\alpha/2}$ is the standard normal quantile for the two-sided significance level $\alpha$ (e.g., $1.96$ for $\alpha = 0.05$).
$Z_{1-\beta}$ represents the standard normal quantile corresponding to statistical power (e.g., $0.842$ for $80\%$ power).

When comparing two continuous normally distributed means with expected difference $\delta = |\mu_1 - \mu_2|$ and pooled standard deviation $\sigma$:

$$n = \frac{2\sigma^2 (Z_{1-\alpha/2} + Z_{1-\beta})^2}{\delta^2}$$

Clinical Trial Worked Example

Consider evaluating a novel anti-hypertensive agent. The established standard of care achieves blood pressure control in $20\%$ of patients ($p_1 = 0.20$). The novel compound is hypothesized to achieve control in $35\%$ of patients ($p_2 = 0.35$).

Define significance threshold: $\alpha = 0.05 \implies Z_{1 - 0.05/2} = 1.960$.
Define target statistical power: $80\% \implies Z_{0.80} = 0.842$.
Calculate average proportion: $\bar{p} = (0.20 + 0.35)/2 = 0.275$.
Applying the formula yields $n \approx 140.4$, which rounds up to 141 participants per arm ($N = 282$ total).

Accounting for Study Attrition & Dropouts

Clinical protocols must adjust for lost to follow-up over the study lifecycle. If an anticipated attrition rate $R$ (e.g., $10\%$) is projected, the target enrollment $n$ is adjusted using:

$$n_{\text{adjusted}} = \frac{n}{1 - R}$$

For our example with $10\%$ anticipated attrition: $141 / (1 - 0.10) \approx 157$ participants per arm.

Academic References

Fleiss, J. L., Levin, B., & Paik, M. C. (2003). Statistical Methods for Rates and Proportions (3rd ed.). John Wiley & Sons.
Rosner, B. (2015). Fundamentals of Biostatistics (8th ed.). Cengage Learning.
Chow, S. C., Shao, J., Wang, H., & Lokhnygina, Y. (2017). Sample Size Calculations in Clinical Research (3rd ed.). Chapman and Hall/CRC.
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Lawrence Erlbaum Associates.

Critical Value Z_1−α/2	1.960
Power Quantile Z_1−β	0.842
Effect Size Metric	\|p₁ − p₂\| = 0.150